Author

Cátia Rebelo de Almeida

Champalimaud FoundationORCID 0000-0002-3617-4470Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:zebrafish· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Rita FioriD· 3 shared Ana Beatriz MachadoiD· 1 shared Ana Rita CarlosiD· 1 shared António JacintoiD· 1 shared Berta SousaiD· 1 shared Bruna CorreiaiD· 1 shared Carolina MathiasiD· 1 shared Catarina M. AzevedoiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Rita FiorORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 26, 2026

CD24 Acts as an Evolutionarily Conserved Innate Immune Checkpoint in Colorectal Cancer

Ana Beatriz Machado, Cátia Rebelo de Almeida, Catarina M. Azevedo…·Rita Fior

This study identifies CD24 as an innate immune checkpoint in colorectal cancer that promotes tumor survival by inhibiting macrophage-mediated clearance, validated through zebrafish models and human data.

DOI 10.64898/2026.08.25.746757

zebrafishproteomics

𝕏 PostBluesky

ImmunologyFrontiers in ImmunologyPeer-reviewedSep 19, 2025

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast Cancer

Rute M. Salvador, Bruna Correia, D.S.C.P. Grosa…·Maria Guadalupe Cabral

This study shows that enhancing HLA-DR expression in cytotoxic T lymphocytes improves their anti-tumor activity, suggesting strategies to optimize adoptive T cell therapies for breast cancer.

5 citations

humanscRNA-seq

𝕏 PostBluesky

Cancer Biologynpj Precision OncologyPeer-reviewedApr 1, 2025

Zebrafish Avatar-test predicts patient's tumor response to chemotherapy in breast cancer: a co-clinical study towards personalized medicine

Raquel Valente Mendes, Joana M. Ribeiro, Helena S. Gouveia…·Rita Fior

The paper develops a zebrafish model to predict breast cancer patient response to chemotherapy, showing perfect correlation between patient and model treatment outcomes.

19 citationstop 2%

zebrafishexperimental assay

𝕏 PostBluesky